Danny Ramirez‘s role in “The Last of Us” will be recast for Season 3 due to scheduling conflicts. Ramirez joined the cast of the HBO apocalypse drama in Season 2. He played Manny, who was described as ...
Eric Law is a Game Rant contributor from Pennsylvania, USA. An MMORPG-focused video game writer for Game Rant for two years and counting, Eric cut his teeth on gaming since he was a wee lad watching ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the ...
Five million World Cup ticket requests “have been submitted in the first 24 hours of the third window of ticket sales,” which opened on Thursday, and the “most sought-after group stage ticket in the ...
Blue Origin’s New Glenn rocket at liftoff during the NG-2 mission on Nov. 13. Credit: Blue Origin The U.S. Space Force is now taking proposals from new launch providers with rockets ready to fly by ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Betelgeuse, one of the largest stars ever discovered, is reaching the end of its life. In the coming centuries or perhaps even right now it could explode into a supernova visible even during the day.
ATLANTA — Eli Lilly’s investigational oral GLP-1 drug orforglipron produced significant weight loss, A1c reduction, and cardiovascular risk factor improvements in the company’s Phase 3 ATTAIN-2 trial ...
IgA nephropathy, the most common primary glomerulopathy worldwide, is a kidney disorder of B-cell origin characterized by mesangial accumulation of IgA-containing immune complexes. In at least 50% of ...
Last Breath – currently trending on Prime Video – tells the gripping story of British oil-rig diver Chris Lemons, who was marooned at the bottom of the North Sea after his support ship's control ...
Kailera Therapeutics has raised $600 million to take its lead obesity program into phase 3. The series B round continues the meteoric rise of Kailera, which exited stealth with $400 million and ...
Copyright: © 2025 The Author(s). Published by Elsevier Ltd. C3 glomerulopathy is an ultra-rare, severe form of glomerulonephritis caused by overactivation of the ...